Reproductive and menstrual factors and thyroid cancer among Japanese women: The Japan collaborative cohort study

Journal of Women's Health

Volumn 18, Issue 3, 2009, Pages 331-335

  Pham, Truong Minh ^a,b   Fujino, Yoshihisa ^a   Mikami, Haruo ^c   Okamoto, Naoyuki ^d   Hoshiyama, Yoshiharu ^e   Tamakoshi, Akiko ^f   Matsuda, Shinya ^a   Yoshimura, Takesumi ^g  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b Thai Nguyen University   (Viet Nam)

^c CHIBA CANCER CENTER   (Japan)

^d KANAGAWA CANCER CENTER   (Japan)

^e SHOWA UNIVERSITY   (Japan)

^f NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g FUKUOKA INSTITUTE OF HEALTH AND ENVIRONMENTAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; FOLLOW UP; HUMAN; JAPANESE; LIVE BIRTH; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; MENSTRUAL CYCLE; PREGNANCY; PRIORITY JOURNAL; QUESTIONNAIRE; REPRODUCTION; THYROID CANCER; WOMEN'S HEALTH;

ADULT; AGED; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; HEALTH STATUS; HUMANS; INCIDENCE; JAPAN; LIFE STYLE; MENARCHE; MIDDLE AGED; ODDS RATIO; REPRODUCTIVE HISTORY; RETROSPECTIVE STUDIES; RISK FACTORS; THYROID NEOPLASMS; WOMEN'S HEALTH;

EID: 62449203276     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2008.1038     Document Type: Article

References (23)

1. Sherman SI. Thyroid carcinoma. Lancet 2003;361:501-511.
2. Colonna M, Grande E, Jonasson JG, Eurocare Working Group. Variation in relative survival of thyroid cancers in Europe: Results from the analysis on 21 countries over the period 1983-1994 (EUROCARE-3 study). Eur J Cancer 2006;42:2598-2608.
3. Parkin DM, Whelan SL, Ferley J, Teppo L, Thomas DB. Cancer incidence in five continents, vol. 8. IARC Scientific Publication No. 155, 2002: International Agency for Research on Cancer, Lyon, France.
4. McTiernan AM, Weiss NS, Daling JR. Incidence of thyroid cancer in women in relation to previous exposure to radiation therapy and history of thyroid disease. J Natl Cancer Inst 1984;73:575-581.
5. Preston DL, Ron E, Tokuoka S, et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res 2007;168:1-64.
6. Tronko MD, Howe GR, Bogdanova TI, et al. A cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident: Thyroid cancer in Ukraine detected during first screening. J Natl Cancer Inst 2006;98:897-903.
7. Pacini F, Vorontsova T, Demidchik EP, et al. Post-Chernobyl thyroid carcinoma in Belarus children and adolescents: Comparison with naturally occurring thyroid carcinoma in Italy and France. J Clin Endocrinol Metab 1997;82:3563-3569.
8. Hegedus L. Thyroid size determined by ultrasound. Influence of physiological factors and non-thyroidal disease. Dan Med Bull 1990;37:249-263.
9. Burrow GN, Fisher DA, Larsen PR. Maternal and fetal thyroid function. N Engl J Med 1994;331:1072-1078.
10. Truong T, Orsi L, Dubourdieu D, Rougier Y, Hemon D, Guenel P. Role of goiter and of menstrual and reproductive factors in thyroid cancer: A population-based case-control study in New Caledonia (South Pacific), a very high incidence area. Am J Epidemiol 2005;161:1056-1065.
11. Mack WJ, Preston-Martin S, Bernstein L, Qian D, Xiang M. Reproductive and hormonal risk factors for thyroid cancer in Los Angeles County females. Cancer Epidemiol Biomarkers Prev 1999;8:991-997.
12. Rossing MA, Voigt LF, Wicklund KG, Daling JR. Reproductive factors and risk of papillary thyroid cancer in women. Am J Epidemiol 2000;151:765-772.
13. Memon A, Darif M, Al-Saleh K, Suresh A. Epidemiology of reproductive and hormonal factors in thyroid cancer: Evidence from a case-control study in the Middle East. Int J Cancer 2002;97:82-89.
14. Sakoda LC, Horn-Ross PL. Reproductive and menstrual history and papillary thyroid cancer risk: The San Francisco Bay Area thyroid cancer study. Cancer Epidemiol Biomarkers Prev 2002;11:51-57.
15. Galanti MR, Hansson L, Lund E, et al. Reproductive history and cigarette smoking as risk factors for thyroid cancer in women: A population-based case-control study. Cancer Epidemiol Biomarkers Prev 1996;5:425-431.
16. Navarro Silvera SA, Miller AB, Rohan TE. Risk factors for thyroid cancer: A prospective cohort study. Int J Cancer 2005;116:433-438.
17. Tamakoshi A, Yoshimura T, Inaba Y, et al. Profile of the JACC Study. J Epidemiol 2005;15 (Suppl 1) S4-8.
18. Ohno Y, Tamakoshi A. Japan Collaborative Cohort Study for evaluation of cancer risk sponsored by Monbusho (JACC Study). J Epidemiol 2001;11:144-150.
19. Kleinbaum DG. Survival analysis. A self-learning text. New York: Springer, 1997.
20. Wood JW, Tamagaki H, Neriishi S, et al. Thyroid carcinoma in atomic bomb survivors, Hiroshima and Nagasaki. Am J Epidemiol 1969;89:4-14.
21. Negri E, Dal Maso L, Ron E, et al. A pooled analysis of case-control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes Control 1999;10:143-155.
22. Rossing MA, Voigt LF, Wicklund KG, Williams M, Daling JR. Use of exogenous hormones and risk of papillary thyroid cancer (Washington, United States). Cancer Causes Control 1998;9:341-349.
23. McTiernan AM, Weiss NS, Daling JR. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors. Am J Epidemiol 1984;120:423-435.